A
Auro Laboratories
AUROLAB Share Price
HealthcareAUROLAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
156
PE Ratio
86.80
PB Ratio
3.71
Dividend Yield
-
ROE
4.28%
ROCE
3.83%
Book Value (₹)
68.95
Face Value (₹)
10.00
Analyse AUROLAB with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 52.18% | 52.18% | 52.18% | 52.18% | 52.18% |
| Domestic Institutional Investors (DII) | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 36.57% | 36.42% | 36.35% | 36.26% | 36.28% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
AUROLAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
530233
NSE Scrip Name
AUROLAB
ISIN
INE292C01011



